Patents by Inventor Philip John LOWE

Philip John LOWE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB
    Publication number: 20250026858
    Abstract: The present disclosure relates to methods for treating Chronic Spontaneous Urticaria using IgE antagonists, e.g., ligelizumab. Also disclosed herein are IgE antagonists, e.g., IgE antibodies, such as ligelizumab, for treating Chronic Spontaneous Urticaria patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: December 20, 2023
    Publication date: January 23, 2025
    Inventors: Reinhold Martin JANOCHA, Stephan KOEHNE-VOSS, Philip John LOWE, Thomas SEVERIN
  • METHODS OF TREATING CHRONIC SPONTANEOUS URTICARIA USING LIGELIZUMAB
    Publication number: 20210115155
    Abstract: The present disclosure relates to methods for treating Chronic Spontaneous Urticaria using IgE antagonists, e.g., ligelizumab. Also disclosed herein are IgE antagonists, e.g., IgE antibodies, such as ligelizumab, for treating Chronic Spontaneous Urticaria patients, as well as medicaments, dosing regimens, pharmaceutical formulations, dosage forms, and kits for use in the disclosed uses and methods.
    Type: Application
    Filed: March 25, 2019
    Publication date: April 22, 2021
    Inventors: Reinhold Martin JANOCHA, Stephan KOEHNE-VOSS, Philip John LOWE, Thomas SEVERIN